TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Rechon Life Science AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
43,794
|
34,889
|
29,887 |
| Financial expenses |
282
|
116
|
103 |
| Earnings before taxes |
5,086
|
5,415
|
2,861 |
| EBITDA |
7,093
|
6,994
|
4,230 |
| Total assets |
32,834
|
29,380
|
27,737 |
| Current assets |
18,474
|
15,121
|
13,143 |
| Current liabilities |
9,091
|
7,173
|
5,201 |
| Equity capital |
18,291
|
15,247
|
12,790 |
| - share capital |
2,482
|
2,475
|
2,693 |
| Employees (average) |
249
|
212
|
184 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
55.7%
|
51.9%
|
46.1% |
| Turnover per employee |
176
|
165
|
162 |
| Profit as a percentage of turnover |
11.6%
|
15.5%
|
9.6% |
| Return on assets (ROA) |
16.3%
|
18.8%
|
10.7% |
| Current ratio |
203.2%
|
210.8%
|
252.7% |
| Return on equity (ROE) |
27.8%
|
35.5%
|
22.4% |
| Change turnover |
8,803
|
7,423
|
-129 |
| Change turnover % |
25%
|
27%
|
0% |
| Chg. No. of employees |
37
|
28
|
9 |
| Chg. No. of employees % |
17%
|
15%
|
5% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.